A space for sharing and discussing news related to global current events, technology, and society.
64608 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
64608 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
3.1K
0
3.1K
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
0
262
0
262
The New York Times: Young U.S. Children Will Start Getting Vaccines, Though Hurdles Remain. >"Although opening up shots for children under 5 is a milestone, this _...Read More_
The New York Times: Young U.S. Children Will Start Getting Vaccines, Though Hurdles Remain. >"Although opening up shots for children under 5 is a milestone, this _...Read More_
0
301
0
301
"The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months."
"The Centers for Disease Control and Prevention’s independent vaccine experts on Saturday backed Pfizer’s and Moderna’s Covid-19 shots for children as young as 6 months."
0
199
0
199
"In deliberations over whether to recommend Covid vaccines for young children, scientific advisers to the Centers for Disease Control and Evaluation on Friday wrestled with the complexities of evaluating two very different vaccines, and _...Read More_
"In deliberations over whether to recommend Covid vaccines for young children, scientific advisers to the Centers for Disease Control and Evaluation on Friday wrestled with the complexities of evaluating two very different vaccines, and _...Read More_
0
217
0
217
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
50
30.6K
50
30.6K
"Scientific advisers to the Centers for Disease Control and Prevention voted unanimously on Saturday to recommend Covid vaccines for children under age 5, the last group of Americans to qualify for the shots, except for infants younger than _...Read More_
"Scientific advisers to the Centers for Disease Control and Prevention voted unanimously on Saturday to recommend Covid vaccines for children under age 5, the last group of Americans to qualify for the shots, except for infants younger than _...Read More_
0
1.5K
0
1.5K
"Pfizer and its German partner, BioNTech, on Wednesday finished submitting an application for regulatory authorization of a coronavirus vaccine for children younger than 5."
"Pfizer and its German partner, BioNTech, on Wednesday finished submitting an application for regulatory authorization of a coronavirus vaccine for children younger than 5."
0
592
0
592
"Scientific advisers to the Centers for Disease Control and Prevention on Thursday recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11."
"Scientific advisers to the Centers for Disease Control and Prevention on Thursday recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11."
55
28.3K
55
28.3K
>"A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have _...Read More_
>"A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have _...Read More_
54
30.5K
54
30.5K
"The Food and Drug Administration is expected to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 as soon as Tuesday, making an extra dose available to protect school-age children as a descendant _...Read More_
"The Food and Drug Administration is expected to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 as soon as Tuesday, making an extra dose available to protect school-age children as a descendant _...Read More_
0
92.7
0
92.7
The Guardian: Pfizer accused of Covid profiteering as first-quarter sales hit $26bn. >"Pharma firm criticised over pricing and for keeping _...Read More_
The Guardian: Pfizer accused of Covid profiteering as first-quarter sales hit $26bn. >"Pharma firm criticised over pricing and for keeping _...Read More_
0
194
0
194
>"Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 _...Read More_
>"Kaiser Permanente finds the Pfizer COVID-19 third dose vaccine protection against hospitalization from omicron wanes after 3 _...Read More_
0
81.8
0
81.8
The New York Times: F.D.A. Panel Weighs Challenges of Revamping Covid Vaccines for Fall. >"A meeting of the committee underscored how many _...Read More_
The New York Times: F.D.A. Panel Weighs Challenges of Revamping Covid Vaccines for Fall. >"A meeting of the committee underscored how many _...Read More_
54
15.5K
54
15.5K
"People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies _...Read More_
"People in the age group can get the additional shot at least four months after their first booster. Those 12 and older with certain immune deficiencies _...Read More_
54
5.4K
54
5.4K
" The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer-BioNTech or Moderna coronavirus vaccine without recommending outright that they get one, according to several people _...Read More_
" The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer-BioNTech or Moderna coronavirus vaccine without recommending outright that they get one, according to several people _...Read More_